NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
Sundia MediTech Company,Ltd. »07/07/2009 [Company watch]
Sundia acquires PFSC technology

Sundia MediTech, an integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China has acquired Protein Folding Shape Code (PFSC) technology for doing probe binding site for drug discovery from Microtech Nano, a R&D company in Indianapolis, US. As part of this business deal, Dr Jiaan Yang, the founder and President of Microtech Nano joins Sundia as Vice President of Drug Discovery Technology.

 
Sundia MediTech, an integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China has acquired Protein Folding Shape Code (PFSC) technology for doing probe binding site for drug discovery from Microtech Nano, a R&D company in Indianapolis, US. As part of this business deal, Dr Jiaan Yang, the founder and President of Microtech Nano joins Sundia as Vice President of Drug Discovery Technology. Dr Yang, in his 26 year professional career in pharmaceutical, biotech and nanotechnology industries, has accumulated a broad range of experience in bioinformatics with expertise in theoretical chemistry, quantum chemistry, computational chemistry, molecular biology and computer information technology. In recent years, Dr Yang quit his job from Eli Lilly and devoted three years to research and to develop an innovative method to describe protein complex 3D structure, and achieved PFSC. With his expertise in multiple fields, Dr Yang applied mathematics on this biology subject, generated a set of PFSC for a complete description of protein\'s complex 3D structure, and developed computer software to process protein data. The success of PFSC is said to be a big scientific breakthrough in structural biology research. Sundia Chairman Dr Xiaochuan Wang said, the application of PFSC technology will bring a great impact to pharmaceutical research and drug discovery. According to her, the PFSC is able to effectively screen protein 3D structure database, probe new indications, explore potential side effects, and help better understanding drug and disease mechanisms on a molecular level and quantitative assessment for ligand-binding site to assist drug design. With PFSC, Sundia can serve our client companies new drug discovery needs more effectively. Scientists like Dr Yang, who has a solid scientific skill set, as well as a strong business mindset and entrepreneurial spirit will greatly enhance our CRO service level, further said Dr Wang.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.